0.67 USD
▲-0.02+9.76%
盘后 0.64 +5.21%
2026-08-03
市值
$18.63M
市盈率
—
EPS
-2.47
股息率
—
52 周区间
0.32 – 3.14
成交量
718.80K
Beta
3.07
目标价
9.17
52W 低 0.3252W 高 3.14
价格走势
公司简介
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company’s lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticar...